CountryOfPapers CountryOfPapers
Journal list Promote Sponsor
verified SJR 0,818 · Q2 • database Scopus / SJR & Web of Science & DOAJ indexed
OncoTargets and Therapy
New Zealand · Dove Medical Press Ltd
workspace_premium Q2 — Oncology visibility_off Single blind Peer Review lock_open Open Access · DOAJ

OncoTargets and Therapy

OncoTargets and Therapy is a journal indexed in SJR in Oncology and Pharmacology (medical) with an H index of 94. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 2079 €. The scope of the journal is focused on oncology, cancer, palliative care, therapeutic agents. It has an SJR impact factor of 0,818 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,818.

OncoTargets and Therapy focuses its scope in these topics and keywords: cancer, cell, lung, factor, nonsmallcell, ovarian, acid, targeting, colorectal, growth, ...

Publisher: Dove Medical Press Ltd
Category: Oncology
Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,818 Q2
H-index 94
Acceptance rate pie_chart
28% Selective
Source Acceptance_Rate
Time to publication hourglass_top
16 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
2.079 € Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

0,818

H-index

94

Docs (year)

91

Docs 3y

660

Total refs

4592

Cites 3y

1836

Citable 3y

655

Cites/Doc 2y

2.78

Ref/Doc

50.46

Immediate OA

2079 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs

What is the SJR of OncoTargets and Therapy?

OncoTargets and Therapy has an SJR of 0,818 (best quartile Q2) in the CountryOfPapers database.

What is the APC / publication cost?

Immediate OA APC is 2079 EUR.

What is the acceptance rate?

The acceptance rate recorded for OncoTargets and Therapy is 28%.